↓ Skip to main content

Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC…

Overview of attention for article published in BMC Neurology, November 2014
Altmetric Badge

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial
Published in
BMC Neurology, November 2014
DOI 10.1186/s12883-014-0220-1
Pubmed ID
Authors

Jonathan Calkwood, Bruce Cree, Heidi Crayton, Daniel Kantor, Brian Steingo, Luigi Barbato, Ron Hashmonay, Neetu Agashivala, Kevin McCague, Nadia Tenenbaum, Keith Edwards

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 13%
Researcher 8 13%
Student > Bachelor 6 10%
Other 6 10%
Student > Ph. D. Student 6 10%
Other 16 27%
Unknown 10 17%
Readers by discipline Count As %
Medicine and Dentistry 21 35%
Neuroscience 6 10%
Nursing and Health Professions 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Psychology 4 7%
Other 8 13%
Unknown 12 20%